Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 Diabetes

被引：221

作者：

Holst, Jens J. ^{[1
]}

Knop, Filip K. ^{[2
]}

Vilsboll, Tina ^{[2
]}

Krarup, Thure ^{[3
]}

Madsbad, Sten ^{[4
]}

机构：

[1] Univ Copenhagen, Panum Inst, Dept Biomed Sci, DK-2200 Copenhagen, Denmark

[2] Gentofte Univ Hosp, Dept Internal Med F, Copenhagen, Denmark

[3] Bispebjerg Hosp, Dept Internal Med T, DK-2400 Copenhagen, Denmark

[4] Univ Copenhagen, Hvidovre Hosp, Dept Endocrinol, DK-2200 Copenhagen, Denmark

来源：

DIABETES CARE | 2011年 / 34卷

关键词：

GLUCAGON-LIKE PEPTIDE-1; GASTRIC-INHIBITORY POLYPEPTIDE; DEPENDENT INSULINOTROPIC POLYPEPTIDE; BETA-CELL FUNCTION; GLUCOSE-TOLERANCE; ORAL GLUCOSE; DEFECTIVE AMPLIFICATION; 1ST-DEGREE RELATIVES; COMMON VARIANTS; DOWN-REGULATION;

D O I：

10.2337/dc11-s227

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：S251 / S257

页数：7

共 65 条

[1] KATP Channel Closure Ameliorates the Impaired Insulinotropic Effect of Glucose-Dependent Insulinotropic Polypeptide in Patients with Type 2 Diabetes [J].

Aaboe, Kasper ;

Knop, Filip Krag ;

Vilsboll, Tina ;

Volund, Aage ;

Simonsen, Ulf ;

Deacon, Carolyn Fiona ;

Madsbad, Sten ;

Holst, Jens Juul ;

Krarup, Thure .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2009, 94 (02) :603-608

[2] Discovery of amino acid variants in the human glucose-dependent insulinotropic polypeptide (GIP) receptor: the impact on the pancreatic beta cell responses and functional expression studies in Chinese hamster fibroblast cells [J].

Almind, K ;

Ambye, L ;

Urhammer, SA ;

Hansen, T ;

Echwald, SM ;

Holst, JJ ;

Gromada, J ;

Thorens, B ;

Pedersen, O .

DIABETOLOGIA, 1998, 41 (10) :1194-1198

[3] NEW DEVELOPMENTS IN THE INCRETIN CONCEPT [J].

CREUTZFELDT, W ;

EBERT, R .

DIABETOLOGIA, 1985, 28 (08) :565-573

[4] Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus [J].

Cuthbertson, Joy ;

Patterson, Steven ;

O'Harte, Finbarr P. ;

Bell, Patrick M. .

METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (01) :52-56

[5] What do we know about the secretion and degradation of incretin hormones? [J].

Deacon, CF .

REGULATORY PEPTIDES, 2005, 128 (02) :117-124

[6] The biology of incretin hormones [J].

Drucker, DJ .

CELL METABOLISM, 2006, 3 (03) :153-165

[7] EFFECT OF SECRETIN ON BASAL-STIMULATED AND GLUCOSE-STIMULATED INSULIN-SECRETION IN MAN [J].

FAHRENKRUG, J ;

SCHAFFALITZKYDEMUCKADELL, OB ;

KUHL, C .

DIABETOLOGIA, 1978, 14 (04) :229-234

[8] Reduced Glucose Tolerance and Insulin Resistance Induced by Steroid Treatment, Relative Physical Inactivity, and High-Calorie Diet Impairs the Incretin Effect in Healthy Subjects [J].

Hansen, K. B. ;

Vilsboll, T. ;

Bagger, J. I. ;

Holst, J. J. ;

Knop, F. K. .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2010, 95 (07) :3309-3317

[9] Inappropriate glucagon response after oral compared with isoglycemic intravenous glucose administration in patients with type 1 diabetes [J].

Hare, Kristine J. ;

Vilsboll, Tina ;

Holst, Jens J. ;

Knop, Filip K. .

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2010, 298 (04) :E832-E837

[10] Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes [J].

Hojberg, P. V. ;

Vilsboll, T. ;

Rabol, R. ;

Knop, F. K. ;

Bache, M. ;

Krarup, T. ;

Holst, J. J. ;

Madsbad, S. .

DIABETOLOGIA, 2009, 52 (02) :199-207

← 1 2 3 4 5 6 7 →